NCT00388349View on ClinicalTrials.gov

Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

March 31, 2008

Study Completion Date

September 30, 2010

Conditions
Hodgkin DiseaseHodgkin's LymphomaLymphoma
Interventions
DRUG

Gemcitabine

DRUG

Vinorelbine

DRUG

Carmustine

DRUG

Etoposide

DRUG

Cyclophosphamide

PROCEDURE

Autologous HCT

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Stanford University

OTHER

NCT00388349 - Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease | Biotech Hunter | Biotech Hunter